SCHEMBL7272491

SCHEMBL7272491

CCCCc1nc(OC)ccc1-c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 5/20 0.47
CLK1 P49759 3/20 0.47
CLK2 P49760 1/20 0.47
CLK3 P49761 1/20 0.47
CDK5 Q00535 1/20 0.47
CDK5R1 Q15078 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
NPC1 O15118 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
RAB9A P51151 2/20 0.39
GSK3B P49841 1/20 0.39
NFKB1 P19838 1/20 0.39
S1PR1 P21453 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7279983 0.92 DYRK1A (0.48) DYRK1ACLK1CLK2CLK3CDK5
SCHEMBL11164012 0.78 GABRP (0.51) CLK4CYP3A4CYP2D6NPC1ALDH1A1
SCHEMBL7280225 0.78 MAPT (0.40) CYP3A4CYP2D6NPC1ALDH1A1MAPT
SCHEMBL11247740 0.75 CYP3A4 (0.37) CLK4CYP3A4CYP2D6NPC1ALDH1A1
SCHEMBL11176428 0.74 CYP3A4 (0.39) CYP3A4CYP2D6NPC1ALDH1A1MAPT
SCHEMBL11074069 0.74 GABRP (0.47) CLK4CYP3A4CYP2D6NPC1ALDH1A1
SCHEMBL7278594 0.74 DYRK1A (0.54) DYRK1ACLK1CLK2CLK3CDK5
SCHEMBL7271215 0.72 CYP19A1 (0.45) DYRK1ACLK1CLK2CLK3CDK5
SCHEMBL26612262 0.71 PDE10A (0.44) PDE10A
SCHEMBL31414676 0.71 PDE10A (0.44) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4463008-A 2-Alkoxy-5-(pyridinyl)pyridines and cardiotonic use thereof STERLING DRUG INC. (US) 1984-07-31 US disclosed
EP-0109027-A1 Pyridine derivatives, process for their preparation and composition containing them STERLING DRUG INC. (US) 1984-05-23 EP disclosed